Association of erythrocyte methotrexate-polyglutamate levels with the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a 76-week prospective study.
about
Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial.Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab.Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study.
P2860
Association of erythrocyte methotrexate-polyglutamate levels with the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a 76-week prospective study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association of erythrocyte met ...... : a 76-week prospective study.
@en
Association of erythrocyte met ...... : a 76-week prospective study.
@nl
type
label
Association of erythrocyte met ...... : a 76-week prospective study.
@en
Association of erythrocyte met ...... : a 76-week prospective study.
@nl
prefLabel
Association of erythrocyte met ...... : a 76-week prospective study.
@en
Association of erythrocyte met ...... : a 76-week prospective study.
@nl
P2093
P2860
P1433
P1476
Association of erythrocyte met ...... : a 76-week prospective study.
@en
P2093
Hiroaki Taguchi
Hisaji Oshima
Keisuke Izumi
Kunihiro Yamaoka
Yuko Kaneko
Yutaka Okano
P2860
P304
P356
10.1136/RMDOPEN-2016-000363
P577
2017-01-03T00:00:00Z